IL-1β and IL-18, generated upon NLRP3 inflammasome activation, emerge as critical pro-inflammatory mediators in innate immunity, exerting a pivotal influence on the initiation and advancement of RA [84]. Here, IL18 is linked to rheumatoid arthritis.